News
06-08-2016, 04:51 AM
A research team, led by Dr. Robert Nagele from Rowan University School of Osteopathic Medicine and Durin Technologies, Inc., has announced the development of a blood test that leverages the body's immune response system to detect an early stage of Alzheimer's disease - referred to as the mild cognitive impairment (MCI) stage - with unparalleled accuracy.
More... (http://www.news-medical.net/news/20160608/New-blood-test-helps-detect-MCI-stagec2a0of-Alzheimers-disease.aspx)
More... (http://www.news-medical.net/news/20160608/New-blood-test-helps-detect-MCI-stagec2a0of-Alzheimers-disease.aspx)